Atria Wealth Solutions’s iShares MSCI ACWI ex US ETF ACWX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$340K Sell
5,579
-15,289
-73% -$883K 0.01% 1097
2025
Q1
$1.16M Buy
20,868
+1,718
+9% +$94.3K 0.01% 824
2024
Q4
$999K Buy
19,150
+2,054
+12% +$112K 0.01% 924
2024
Q3
$978K Buy
17,096
+9,542
+126% +$520K 0.01% 922
2024
Q2
$401K Buy
+7,554
New +$403K ﹤0.01% 1341
2024
Q1
Sell
-4,858
Closed -$248K 1957
2023
Q4
$248K Buy
+4,858
New +$234K ﹤0.01% 1634
2023
Q2
Sell
-10,563
Closed -$515K 1862
2023
Q1
$515K Sell
10,563
-7,505
-42% -$361K 0.01% 1113
2022
Q4
$822K Sell
18,068
-13,053
-42% -$573K 0.01% 849
2022
Q3
$1.25M Sell
31,121
-7,973
-20% -$355K 0.02% 641
2022
Q2
$1.76M Buy
39,094
+803
+2% +$38.9K 0.03% 491
2022
Q1
$2M Buy
+38,291
New +$2.04M 0.03% 484

Other funds holding ACWX

Atria Wealth Solutions's ACWX Position: Q2 2025 in Review

Atria Wealth Solutions reduced its iShares MSCI ACWI ex US ETF (ACWX) stake by 73% in Q2 2025, selling an estimated $883K and leaving 5,579 shares worth $340K. The position accounts for 0.01% of the portfolio, ranked #1097.

Atria Wealth Solutions first reported a position in ACWX in Q1 2022 and has held it in 11 quarters since. The position peaked at $2M in Q1 2022. 534 funds tracked by Wall St. Rank hold ACWX as of Q2 2025.

  • Atria Wealth Solutions held 5,579 shares of iShares MSCI ACWI ex US ETF worth $340K as of Q2 2025.
  • Atria Wealth Solutions sold 15,289 iShares MSCI ACWI ex US ETF shares in Q2 2025, an estimated $883K.
  • iShares MSCI ACWI ex US ETF made up 0.01% of Atria Wealth Solutions's portfolio in Q2 2025, its #1097 holding.
  • Atria Wealth Solutions first reported a position in iShares MSCI ACWI ex US ETF in Q1 2022 and has held it in 11 quarters since.
  • Atria Wealth Solutions's iShares MSCI ACWI ex US ETF position peaked at $2M in Q1 2022.
  • 534 funds tracked by Wall St. Rank held iShares MSCI ACWI ex US ETF as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.